In This Article
The short answer: Eosinophils are immune cells that regulate parasitic defense, allergic responses, and tissue homeostasis. Mildly elevated eosinophils (500-1500 cells per microliter) are usually explained by allergies, asthma, or antiparasitic response. Levels above 1500 warrant investigation. Levels above 5000 (hypereosinophilia) require urgent medical evaluation due to risk of end-organ damage. Context from your clinical history matters more than a single number.
Read key takeaways →
What eosinophils are and what they do
Eosinophils are white blood cells produced in bone marrow and primarily deployed in connective tissues, the gastrointestinal tract, and the respiratory epithelium. They make up 1-5% of circulating white blood cells in a normal differential count, translating to roughly 100-500 cells per microliter of blood.
Their evolutionary primary function is defense against parasitic helminths (worms). They are also central mediators of allergic inflammation and asthma, releasing cytotoxic granule proteins (major basic protein, eosinophil cationic protein) that can damage target cells. This makes them an effective weapon against parasites and a source of tissue damage when chronically activated by allergens or autoimmune triggers.
Eosinophil Reference Ranges
Normal: 100-500
1-5% of white blood cell differential. No clinical significance in isolation. Context-dependent: higher end of normal in someone with known seasonal allergies is unremarkable.
Mild: 500-1500
Mild eosinophilia. Almost always explained by allergies, asthma, eczema, or antiparasitic response. Confirm clinical history. Repeat in 4-6 weeks if no obvious explanation.
Moderate: 1500-5000
Investigate further. Medication review, parasite screen (stool O&P), food allergy panel, imaging if GI symptoms. Eosinophilic GI disorders, drug reactions, and occult parasitic infections are in the differential.
Severe: above 5000
Hypereosinophilia. Urgent evaluation for hypereosinophilic syndrome (HES), clonal hematologic disorders, or severe parasitic infection. Risk of end-organ damage (cardiac, pulmonary, neurologic) at sustained levels above 1500 when tissue infiltration occurs.
The absolute count matters more than the percentage. A differential showing 8% eosinophils with a low total white cell count may be fewer absolute eosinophils than 3% in someone with leukocytosis. Always use the absolute eosinophil count (AEC) from the complete blood count, not just the percentage.
The most common causes of elevated eosinophils
The NAACP mnemonic is a useful clinical framework for the differential diagnosis of eosinophilia. The most common causes in Western adults are allergic: atopy (allergic rhinitis, asthma, eczema) accounts for the majority of mild eosinophilia found incidentally on routine bloodwork.
Primary causes by frequency (Western adults)
- →Atopic disease: Allergic rhinitis, asthma, atopic dermatitis (eczema). Most common cause of mild-to-moderate eosinophilia. Seasonal variation is common: pollen season often raises AEC by 30-50%.
- →Drug reactions: NSAIDs, antibiotics (especially penicillins and cephalosporins), anticonvulsants, and some antihypertensives can trigger eosinophilia. DRESS syndrome (drug reaction with eosinophilia and systemic symptoms) is a severe but rare form. Always review any new medications.
- →Parasitic infection: Tissue-invasive helminths (Toxocara, Strongyloides, Toxoplasma) produce sustained eosinophilia. Strongyloides is particularly important in returned travelers and immunocompromised individuals because it can cause fatal hyperinfection.
- →Eosinophilic GI disorders: Eosinophilic esophagitis (EoE), eosinophilic gastritis, eosinophilic colitis. Increasingly recognized. EoE is now the most common cause of dysphagia in young men.
- →Connective tissue and autoimmune: Eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss), inflammatory bowel disease, rheumatoid arthritis. Less common but important to exclude at higher counts.
Gotlib (Stanford) and other hematologists emphasize that the most dangerous assumption is that mild eosinophilia in a young, otherwise healthy-appearing person is always allergic. Strongyloides stercoralis in particular can produce eosinophilia for decades in asymptomatic individuals and cause life-threatening dissemination with immunosuppression (including corticosteroids, which are often prescribed for allergy and asthma).
Eosinophils and systemic inflammation markers
Eosinophilia and hs-CRP (high-sensitivity C-reactive protein) measure different things. hs-CRP reflects acute-phase response driven primarily by IL-6 and is elevated in metabolic syndrome, obesity, cardiovascular risk, and acute infection. Eosinophilia reflects type 2 immune activation driven by IL-4, IL-5, and IL-13, and is elevated in allergic and parasitic conditions.
Common Misconception
High eosinophils do not indicate systemic inflammation the same way elevated hs-CRP does. A person with seasonal allergies may have eosinophils at 800 cells per microliter and a completely normal hs-CRP. These are parallel immune pathways. Treating high eosinophils as a general inflammation marker and concluding you have metabolic or cardiovascular inflammation is a misreading of the test.
There is one important intersection: eosinophilic airway inflammation in severe asthma is now a therapeutic target. Dupilumab (anti-IL-4/IL-13), mepolizumab (anti-IL-5), and benralizumab (anti-IL-5R) all reduce eosinophilic inflammation specifically. These biologic therapies are indicated for eosinophil-driven severe asthma with AEC above 150-300, depending on the agent and indication.
For context on metabolic and cardiovascular inflammation markers, see the Lab Work and Biomarkers Protocol.
When to act and what to do next
The clinical action depends on the level and the context. Mild elevation (500-1500) in someone with a documented history of allergic rhinitis or asthma who has a normal exam, no GI symptoms, and no recent travel to endemic areas: reasonable to repeat in 4-6 weeks and monitor. Most will normalize or remain stable at a mildly elevated baseline.
Decision framework by count and context
- →500-1500, known atopy, no symptoms: Repeat CBC in 4-6 weeks. If stable and consistent with allergy history, observe. Review current medications for any new additions.
- →500-1500, no clear explanation: Medication review, parasite screen (stool O&P x3, Strongyloides serology if any travel history), food allergy panel if GI symptoms, repeat CBC in 4-6 weeks.
- →1500-5000: Same as above plus: imaging if GI symptoms, pulmonary function testing if respiratory symptoms, IgE level, allergy panel, consultation with allergist or hematologist.
- →Above 5000 (any context): Urgent hematology evaluation. Hypereosinophilic syndrome workup including echocardiography (Loeffler endocarditis), chest X-ray, and bone marrow biopsy if clonal etiology suspected.
Corticosteroids reduce eosinophil counts rapidly and dramatically. This is why eosinophilia can appear to "resolve" if a patient has been given steroids for another reason. If you have been on oral steroids within the past 4 weeks, your eosinophil count may be falsely normalized. A baseline count should be measured before steroid initiation when possible, or 4-6 weeks after completion.
The Strongyloides risk
Strongyloides stercoralis is a soil-transmitted nematode endemic in tropical and subtropical regions (Southeast Asia, sub-Saharan Africa, parts of Latin America). It can establish chronic infection in asymptomatic individuals for decades. In anyone with unexplained eosinophilia and any history of travel to endemic regions, Strongyloides serology (ELISA) should be ordered before prescribing corticosteroids or other immunosuppressants. If undetected and steroids are given, hyperinfection syndrome can be fatal. This is a clinical scenario that requires explicit awareness.
Frequently Asked Questions
My eosinophils are 650 and I have seasonal allergies. Should I be worried?
Almost certainly not. Mild eosinophilia in the 500-1000 range in someone with documented atopic disease (allergic rhinitis, asthma, eczema) is the most common finding in routine bloodwork and is consistent with the underlying allergic inflammation. If your allergies are active and it is pollen season, a count in this range is expected. Recheck in 4-6 weeks, ideally outside peak allergy season. If it has been stable for multiple readings, it is baseline for your immune phenotype.
Can stress or poor sleep elevate eosinophils?
Directly, no. Chronic stress elevates cortisol, which actually suppresses eosinophil counts (corticosteroids are used clinically to reduce eosinophilia). Poor sleep elevates inflammatory markers like hs-CRP and IL-6, but these are type 1 inflammatory pathway markers. Eosinophils are type 2. Sleep deprivation research does not consistently show eosinophil elevation as a downstream effect. If you have both elevated hs-CRP and elevated eosinophils, those are likely two separate explanations.
What is the difference between eosinophilia and eosinophilic disorders?
Eosinophilia is an elevated count in blood. Eosinophilic disorders are conditions defined by eosinophil tissue infiltration causing organ dysfunction, regardless of whether the blood count is elevated. Eosinophilic esophagitis can occur with a normal blood AEC. Eosinophilic granulomatosis with polyangiitis (EGPA) usually has a dramatically elevated AEC. The distinction matters because blood count normalization with treatment does not always indicate tissue-level resolution.
How often should I recheck eosinophils if they are mildly elevated?
If the first finding is mild (500-1500) with a plausible explanation (allergies, recent travel, new medication), recheck at 4-6 weeks. If stable and the clinical context is unchanged, annual monitoring as part of routine bloodwork is reasonable. If eosinophils are persistently above 1000 without clear explanation across two readings, a more thorough evaluation is appropriate rather than continued watchful waiting.
Can diet or supplements affect eosinophil counts?
Not directly in healthy adults without food allergies. Eosinophilic esophagitis and eosinophilic GI disorders can be driven by specific food antigens, most commonly milk, wheat, eggs, soy, nuts, and seafood. In those conditions, elimination diets demonstrably reduce tissue eosinophilia and can improve blood counts. But a standard Western diet without specific food allergy is not a meaningful driver of eosinophil levels. Fish oil (omega-3) has modest anti-inflammatory effects on the allergic pathway via reduced leukotriene synthesis, but the clinical magnitude is small.
What to Remember
- →Mild eosinophilia (500-1500 cells per microliter) in people with allergies or asthma is usually a reflection of the underlying allergic immune phenotype, not a new or dangerous finding.
- →Always use the absolute eosinophil count from the CBC, not the percentage, which can mislead when total white cell count is abnormal.
- →Moderate eosinophilia (1500-5000) requires investigation: medication review, Strongyloides serology if any travel history, parasite screen, and allergy evaluation.
- →Never start corticosteroids in someone with unexplained eosinophilia and travel history to Strongyloides-endemic regions without first testing for it. Steroid-induced hyperinfection can be fatal.
- →High eosinophils and elevated hs-CRP are different inflammatory pathways. Do not conflate them as a single inflammation signal.
- →Severe hypereosinophilia (above 5000) requires urgent evaluation for hypereosinophilic syndrome due to risk of cardiac, pulmonary, and neurologic end-organ damage from tissue infiltration.
Related on Protocol
Lab Work and Biomarkers Protocol
The full framework for interpreting blood markers, from inflammation to hormones to metabolic health.
How to Interpret Your Lipid Panel
LDL particles, ApoB, and what actually matters in cardiovascular risk assessment.
What Your Thyroid Numbers Mean
TSH, free T3, free T4, and their implications for energy and body composition.
Track your lab trends over time
Protocol stores your biomarker history, flags out-of-range values in context, and shows how markers like eosinophils trend alongside your inflammatory and metabolic picture.
Get started freeReferences
Key Researchers
- Cezmi Akdis (Swiss Institute of Allergy and Asthma Research) Type 2 immune response mechanisms and eosinophil biology in allergic disease. Work on IL-4, IL-5, IL-13 pathways and their therapeutic targeting.
- Marc Rothenberg (Cincinnati Children's Hospital) Pioneer in eosinophilic gastrointestinal diseases, particularly eosinophilic esophagitis. Established EoE as an antigen-driven eosinophilic disorder.
- Jason Gotlib (Stanford University) Hematologic malignancies and hypereosinophilic syndrome. Research on clonal eosinophilias and molecular driver mutations.
Key Studies
- Uhm et al. (2012) Journal of Korean Medical Science. Prevalence and causes of eosinophilia in a general population cohort. Found allergic disease accounted for greater than 50% of mild eosinophilia cases.
- Klion et al. (2009) Blood. Hypereosinophilic syndrome: current approach to diagnosis and treatment. Defined diagnostic criteria and management framework for HES including end-organ assessment.
- Rothenberg & Hogan (2006) Annual Review of Immunology. Comprehensive review of eosinophil biology, granule proteins, and role in type 2 immune responses. Foundational reference for mechanism understanding.
